Pradeep Bhadauria
Chief Tech/Sci/R&D Officer en CIPLA LIMITED .
Cargos activos de Pradeep Bhadauria
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CIPLA LIMITED | Chief Tech/Sci/R&D Officer | 01/01/2020 | - |
President | 01/01/2020 | - |
Historial de carrera de Pradeep Bhadauria
Antiguos cargos conocidos de Pradeep Bhadauria.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 02/04/2019 | - |
Formación de Pradeep Bhadauria.
Birla Institute of Technology & Science | Graduate Degree |
Shri Govindram Seksaria Institute of Technology & Science | Undergraduate Degree |
Estadísticas
Internacional
India | 4 |
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
President | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CIPLA LIMITED | Health Technology |
Empresas privadas | 1 |
---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Pradeep Bhadauria
- Experiencia